收藏切换
Establishment of a new genus of filovirus (Mengla virus) entry evaluating system and entry inhibitors discovery
收藏切换
PDF
Qing CHEN, Pan-pan CHEN, Yi-jing XIN, Ke TANG, Xiao-yu ZHANG, Ying GUO*
Acta Pharmaceutica Sinica | 2019, 54(9) : 1612 - 1619
Less
收藏切换
Acta Pharmaceutica Sinica | 2019, 54(9): 1612-1619
Original Articles
Establishment of a new genus of filovirus (Mengla virus) entry evaluating system and entry inhibitors discovery
Full
Qing CHEN, Pan-pan CHEN, Yi-jing XIN, Ke TANG, Xiao-yu ZHANG, Ying GUO*
Affiliations
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2019-09-12 doi: 10.16438/j.0513-4870.2019-0420
Outline
收藏切换

Mengla virus (MLAV), isolated from the bats in China, was identified as a new genus of filovirus in 2019, i.e. Dianlovirus genus of Filoviridae family. Among filoviruses, Ebola virus (EBOV) and Marburg virus (MARV) are the most contagious viruses with mortality rates of 24%-90%. Phylogenetic analysis showed that MLAV was closely related to MARV among the members of filovirus family. MLAV enters into host cells via viral glycoprotein (GP). The recombinant virus study indicated that MLAV has a potential for bat-to-human cross-species transmission. In this study, a GP-mediated MLAV entry evaluating model was established, and by using this model, we investigated the susceptibility of MLAV to the human cell lines sourced from different tissues and the African green monkey kidney cell lines. Four compounds, chloroquine, tetrandrine, clomiphene, and toremifene, which were known as EBOV and MARV entry blockers, were tested for HIV/MLAV-GP infection. It was found that chloroquine effectively blocked the entry of MLAV with the half maximal effective concentration (EC50) of 1.56 μmol·L-1, resembling its anti-EBOV and -MARV activities. To the best of our acknowledge, there is no anti-MLAV drug reported by far, and the identification of chloroquine as an MLAV entry inhibitor may provide an insight for developing anti-filovirus agents.

Mengla virus  /  filovirus  /  entry  /  chloroquine
Qing CHEN, Pan-pan CHEN, Yi-jing XIN, Ke TANG, Xiao-yu ZHANG, Ying GUO. Establishment of a new genus of filovirus (Mengla virus) entry evaluating system and entry inhibitors discovery[J]. Acta Pharmaceutica Sinica, 2019 , 54 (9) : 1612 -1619 . DOI: 10.16438/j.0513-4870.2019-0420
Year 2019 volume 54 Issue 9
PDF
129
51
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2019-0420
  • Receive Date:2019-05-28
  • Online Date:2026-01-26
  • Published:2019-09-12
Article Data
Affiliations
History
  • Received:2019-05-28
  • Revised:2019-07-02
Funding
Affiliations
    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2019-0420
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT